Hoitt Jason
Stoke Therapeutics, Inc. · Chief Patient Officer
Hoitt Jason is listed in public filings as officer: Chief Patient Officer. This Hoitt Jason insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Stoke Therapeutics, Inc. (STOK). Investors use Hoitt Jason's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $328k10.3k shares | SellMar 18, 2026 | $4.4K139 shares | $31.79 | -- | |
| $338k10.3k shares | SellMar 18, 2026 | $98630 shares | $32.85 | -- | |
| $327k10.4k shares | SellMar 18, 2026 | $55.1K1.8k shares | $31.28 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $424k13k shares | SellMar 17, 2026 | $33.8K1k shares | $32.74 | -- | |
| $407k12.2k shares | SellMar 17, 2026 | $25.0K748 shares | $33.38 | -- | |
| --14k shares | Grant / ExerciseMar 15, 2026 | Disclosure amount unavailable10k shares | -- | -- | |
| $2.2M72k shares | Grant / ExerciseFeb 17, 2026 | $2.2M72k shares | $31.09 | -- | |
| --48k shares | Grant / ExerciseFeb 17, 2026 | Disclosure amount unavailable48k shares | -- | -- |